Introduction ctDNA ctDNA Testing in Oncology Tumor Profiling TissueBased Testing and PlasmaBased Testing Possible Role of PlasmaBased Molecular Profiling Testing Challenges of Analyzing ctDNA ID: 781566
Download The PPT/PDF document "Advances in Guiding Treatment Selection ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Advances in Guiding Treatment Selection for Patients With Cancer
Slide2Slide3Introduction
Slide4ctDNA
Slide5ctDNA Testing in Oncology
Slide6Tumor Profiling: Tissue-Based Testing and Plasma-Based Testing
Slide7Possible Role of Plasma-Based Molecular Profiling Testing
Slide8Challenges of Analyzing ctDNA
Slide9Characteristics of an Ideal ctDNA Assay
Slide10Methodologies Used in ctDNA NGS Assays
Slide11Selected Commercial ctDNA NGS Assays
Slide12Best Practices for Choosing Among Panels
Faculty Insight
Slide13Practical Clinical Challenges of ctDNA Testing
Slide14Technical Challenges With Incorporating ctDNA NGS Testing
Slide15Technical Challenges With Incorporating ctDNA NGS Testing (cont)
Slide16Considerations Regarding Matched Testing
Slide17Digital PCR in ctDNA Testing
Slide18Potential Future Applications of ctDNA Testing
Slide19Communication Is Critical
Slide20Key Takeaways
Slide21Key Takeaways (cont)
Slide22Abbreviations